Chromatin/Epigenetics
Chromatin/epigenetics inhibitors are compounds that modulate the structure and function of chromatin or interfere with epigenetic modifications, such as DNA methylation and histone modification. These inhibitors are essential tools for studying gene expression regulation and the role of epigenetics in diseases like cancer, neurological disorders, and developmental abnormalities. By targeting epigenetic processes, these inhibitors can alter gene expression patterns and offer new therapeutic avenues. At CymitQuimica, we provide a wide selection of high-quality chromatin/epigenetics inhibitors to support your research in molecular biology, genetics, and epigenetics.
Subcategories of "Chromatin/Epigenetics"
Found 2235 products of "Chromatin/Epigenetics"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
JAK3-IN-9
CAS:<p>JAK3-IN-9, potent JAK3 inhibitor, IC50 of 1.7 nM, highly selective, low toxicity, orally bioavailable, shows anti-arthritis activity.</p>Formula:C17H23N5O4SColor and Shape:SolidMolecular weight:393.46PARP-2/1-IN-2
CAS:<p>PARP-2/1-IN-2, Veliparib's enantiomer, inhibits PARP-1/2 (Ki: 5/2 nM) with 3 nM EC50 in cell assay.</p>Formula:C13H16N4OColor and Shape:SolidMolecular weight:244.29ZLD10A
CAS:<p>ZLD10A is a highly potent and selective small molecule inhibitor of EZH2.</p>Formula:C37H48N4O4Purity:98%Color and Shape:SolidMolecular weight:612.8WAY-260022
CAS:<p>WAY-260022 is the norepinephrine transporter inhibitor.</p>Formula:C21H31F3N2O2Purity:97.61% - 99.41%Color and Shape:SolidMolecular weight:400.48LB-205
CAS:<p>LB-205 is a Zn 2+ dependent pan-inhibitor of class I and class II HDACs. It also has a long half-life in vivo.</p>Formula:C18H21N3O2SColor and Shape:SolidMolecular weight:343.44CBP/p300-IN-10
CAS:<p>CBP/p300-IN-10, potent EP300/CREBBP inhibitor; IC50: 26 nM/39 nM. Potential for cancer research.</p>Formula:C25H24F5N5O3Color and Shape:SolidMolecular weight:537.48INCB16562
CAS:<p>INCB16562: oral JAK1/2 inhibitor, halts IL-6/STAT3 in myeloma cells, boosts drug efficacy, stunts myeloma in mice.</p>Formula:C19H11Cl2N5Color and Shape:SolidMolecular weight:380.23Guadecitabine
CAS:<p>Guadecitabine is a second-generation DNA methyltransferases inhibitor. It is used for research on acute myeloid leukemia and myelodysplastic syndromes.</p>Formula:C18H24N9O10PPurity:98%Color and Shape:SolidMolecular weight:557.41Aurora A/PKC-IN-1
CAS:<p>Aurora A/PKC-IN-1 inhibits AurA (IC50: 6.9 nM), PKCα (IC50: 16.9 nM), and hinders breast cancer cell growth and spread.</p>Formula:C16H14N6OSe2Color and Shape:SolidMolecular weight:464.24PRMT5-IN-10
CAS:<p>PRMT5-IN-10 exhibits promising structure-dependent inhibitory effect on the protein methyltransferase PRMT5:MEP50 complex.</p>Formula:C13H17N5O4Color and Shape:SolidMolecular weight:307.31DDO-2093 dihydrochloride
<p>DDO-2093 dihydrochloride: potent MLL1-WDR5 inhibitor, IC50=8.6 nM, Kd=11.6 nM, antitumor.</p>Formula:C29H39Cl3FN9O3Color and Shape:SolidMolecular weight:687.04Depudecin
CAS:<p>Depudecin, a polyketide from Alternaria brassicicola, has an 11-carbon chain with two epoxides and six stereocenters, inhibits HDAC, and is anti-angiogenic.</p>Formula:C11H16O4Color and Shape:SolidMolecular weight:212.24UNC0379 TFA
CAS:<p>UNC0379 TFA inhibits SETD8 (IC50: 7.3 μM), selective for 15+ methyltransferases.</p>Formula:C25H36F3N5O4Color and Shape:SolidMolecular weight:527.589Bromodomain inhibitor-8
CAS:<p>Bromodomain inhibitor-8 is an inhibitor of BET bromodomain used to treat autoimmune and inflammatory diseases.</p>Formula:C26H25ClN2O3Color and Shape:SolidMolecular weight:448.94F-amidine
CAS:<p>F-amidine is a bioavailable irreversible PAD4 inactivator.</p>Formula:C14H19FN4O2Color and Shape:SolidMolecular weight:294.32JNJ-9350
CAS:<p>JNJ-9350: SMOX inhibitor (IC50 0.01 μM), PAO inhibitor (IC50 0.79 μM), for cancer research.</p>Formula:C25H22N6OColor and Shape:SolidMolecular weight:422.48CPI-455 HCl
CAS:<p>CPI-455: specific KDM5A inhibitor, IC50=10±1nM, increases H3K4me3, reduces DTPs in cancer cells.</p>Formula:C16H15ClN4OPurity:98%Color and Shape:SolidMolecular weight:314.77ZL0454
CAS:<p>ZL0454 is an effective and selective Bromodomain-containing protein 4 inhibitors (IC50: 49 and 32 nM for BD1 and BD2).</p>Formula:C18H22N4O3SPurity:98%Color and Shape:SolidMolecular weight:374.46S2101
CAS:<p>S2101 is a specific LSD1 histone demethylase inhibitor with an IC50 of 0.99 μM and a Ki of 0.61 μM, suitable for research into cancer and viral infections.</p>Formula:C16H16ClF2NOPurity:98%Color and Shape:SolidMolecular weight:311.75LEM-14-1189
CAS:<p>LEM-14-1189 inhibits NSD1/2/3 (IC50: 418/111/60 μM), targets nuclear receptors, and may treat cancer and blood diseases.</p>Formula:C35H34N6O5S2Purity:98.06%Color and Shape:SolidMolecular weight:682.81BRD4-BD1-IN-2
CAS:<p>BRD4-BD1-IN-2: Potent, selective BRD4-BD1 inhibitor, IC50=2.51µM; 20x less active on BD2; for cardiovascular/cancer research.</p>Formula:C20H15Br3N4O2Purity:99.39%Color and Shape:SolidMolecular weight:583.07PI3K/HDAC-IN-1
CAS:<p>PI3K/HDAC-IN-1 is a potent PI3K and HDAC dual inhibitor(IC50s of 8.1 nM and 1.4 nM, respectively).</p>Formula:C22H25FN4O4Purity:98%Color and Shape:SolidMolecular weight:428.46MAT2A-IN-4
CAS:<p>MAT2A-IN-4 can be used for the cancer research that is an inhibitor of methionine adenosyltransferase 2A (MAT2A)[1].</p>Formula:C18H16ClN3OColor and Shape:SolidMolecular weight:325.79SIRT5 inhibitor 2
CAS:<p>SIRT5 inhibitor 2 (compound 49) has inhibitory activity through SIRT5-dependent deacetylation and cancer and neurodegenerative diseases.</p>Formula:C18H12Cl2N2O3SPurity:99.38% - 99.87%Color and Shape:SolidMolecular weight:407.27MC4343
<p>MC4343, a potent dual inhibitor targeting both EZH2 and histone deacetylase, presents promising potential for cancer research applications.</p>Formula:C36H41N5O4Color and Shape:SolidMolecular weight:607.74Furamidine dihydrochloride
CAS:<p>Furamidine dihydrochloride is a cell-permeable, selective PRMT1 inhibitor that also binds AT-rich DNA. It blocks proliferation in leukemia cell lines.</p>Formula:C18H18Cl2N4OPurity:98.16%Color and Shape:SolidMolecular weight:377.27KD 5170
CAS:<p>KD 5170, a pan inhibitor of histone deacetylases (HDACs), demonstrates widespread antitumor activity both in vitro and in vivo [1].</p>Formula:C20H25N3O5S2Color and Shape:SolidMolecular weight:451.561,2,3,4,5,6-Hexabromocyclohexane
CAS:<p>Inhibits JAK2 autophosphorylation; non-cytotoxic at 100μM; 1μM reduces activity by 50%, 50μM nearly abolishes it.</p>Formula:C6H6Br6Purity:98%Color and Shape:SolidMolecular weight:557.54Bromodomain inhibitor-9
CAS:<p>Bromodomain inhibitor-9 selectively targets BRD4-1 (Kd 12 nM), used in metabolic, inflammatory, fibrotic, and autoimmune disease studies.</p>Formula:C24H28N4O5SColor and Shape:SolidMolecular weight:484.57SYK/JAK-IN-1
CAS:<p>SYK/JAK-IN-1 is a dual SYK/JAK inhibitor with IC50 values of less than 5 nM for both SYK and JAK2.</p>Formula:C24H26N8O3Color and Shape:SolidMolecular weight:474.52Tankyrase-IN-2
CAS:<p>Tankyrase-IN-2 is a selective, potent and orally active inhibitor of tankyrase with IC50s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively</p>Formula:C17H14F2N2O2Purity:98%Color and Shape:SolidMolecular weight:316.3NSC-311068
CAS:<p>NSC-311068: A selective TET1 inhibitor, reducing 5hmC and AML cell viability with high TET1.</p>Formula:C10H6N4O4SColor and Shape:SolidMolecular weight:278.24GNE-272
CAS:<p>GNE-272 is a selective inhibitor of CBP/EP300 (IC50: 0.02, 0.03, and 13 μM for CBP, EP300, and BRD4, respectively) and a selective in vivo probe for CBP/EP300.</p>Formula:C22H25FN6O2Color and Shape:SolidMolecular weight:424.47SD-1029
CAS:<p>SD-1029 is a JAK2 inhibitor and a novel Stat3 activation inhibitor that inhibits Stat3 phosphorylation and JAK-STAT signaling.</p>Formula:C25H32Br2Cl2N2O3Color and Shape:SolidMolecular weight:639.256(5H)-Phenanthridinone
CAS:<p>6(5H)-Phenanthridinone suppresses PARP1/2, reduces RDM4 cell growth, downregulates pro-inflammatory genes, and alleviates EAE symptoms in rats.</p>Formula:C13H9NOColor and Shape:SolidMolecular weight:195.22NCC-149
CAS:<p>NCC-149 is a HDAC8 inhibitor.</p>Formula:C16H14N4O2SColor and Shape:SolidMolecular weight:326.37MS-1020
CAS:<p>MS-1020 inhibits JAK3/STAT3, blocks active JAK3, suppresses JAK3/STAT5 signaling, and targets STAT3 in certain cells.</p>Formula:C21H18N2O3Purity:98%Color and Shape:SolidMolecular weight:346.38AC-93253 iodide
CAS:<p>AC-93253 iodide is a selective inhibitor of SIRT2. It significantly enhances the acetylation of tubulin p53 and histone H4.</p>Formula:C23H25IN2SPurity:98%Color and Shape:SolidMolecular weight:488.43Jaspamycin
CAS:<p>Jaspamycin (7-CN-7-C-Ino) does not bind with purified human PKARIα.</p>Formula:C12H12N4O5Color and Shape:SolidMolecular weight:292.25Ac-Lys-AMC
CAS:<p>Ac-Lys-AMC (Hexanamide) is a fluorescent substrate for histone deacetylase HDACs.</p>Formula:C18H23N3O4Purity:98%Color and Shape:SolidMolecular weight:345.39(R)-UT-155
CAS:<p>(R)-UT-155 is a selective androgen receptor degrader (SARD) ligand.</p>Formula:C20H15F4N3O2Color and Shape:SolidMolecular weight:405.35ZYJ-34v
CAS:<p>ZYJ-34v is an oral histone deacetylase inhibitor (HDACi) with potent antitumor activities.</p>Formula:C27H35N3O6Purity:98%Color and Shape:SolidMolecular weight:497.58TUL01101
CAS:<p>TUL01101, a selective oral JAK1 inhibitor (IC50: 3 nM), also targets JAK2, JAK3, TYK2; for rheumatoid arthritis research.</p>Formula:C22H25F2N5O2Color and Shape:SolidMolecular weight:429.46ARTD10/PARP10-IN-1
CAS:<p>ARTD10/PARP10-IN-1 is a PARP inhibitor that inhibits ARTD8/PARP14 and has anticancer and antitumour activity for the study of prostate cancer.</p>Formula:C12H12N2O4Purity:99.14%Color and Shape:SolidMolecular weight:248.23BPTF-IN-1
CAS:<p>BPTF-IN-1 (AU1), a BPTF bromodomain inhibitor with 2.8 μM affinity, shows higher selectivity over BRD4 and possesses antimalarial properties.</p>Formula:C23H23FN6O3Color and Shape:SolidMolecular weight:450.47CPI-4203
CAS:<p>CPI-4203 is a selective inhibitor of KDM5 demethylases.</p>Formula:C16H14N4OColor and Shape:SolidMolecular weight:278.31LSD1-IN-13
CAS:<p>LSD1-IN-13, an oral LSD1 blocker (IC50: 24.43 nM), boosts CD86 (EC50: 470 nM), and triggers AML cell line differentiation.</p>Formula:C23H29N3O2SColor and Shape:SolidMolecular weight:411.56BI-9321
CAS:<p>BI-9321: Selective NSD3-PWWP1 antagonist, Kd 166 nM. Inactive against NSD2-PWWP1/NSD3-PWWP2.</p>Formula:C22H21FN4Purity:98%Color and Shape:SolidMolecular weight:360.43SHP2/HDAC-IN-1
CAS:<p>SHP2/HDAC-IN-1: dual SHP2/HDAC inhibitor, IC50: 20.4 nM/25.3 nM, boosts antitumor immunity, aids cancer immunotherapy research.</p>Formula:C34H35Cl2N7O3Color and Shape:SolidMolecular weight:660.59Acefylline piperazine
CAS:<p>Acefylline piperazine, a less toxic theophylline derivative, treats asthma and bronchitis by bronchodilation, stimulating respiration and CNS.</p>Formula:C9H10N4O4·xC4H10N2Color and Shape:SolidMolecular weight:562.54PKN1/2-IN-1
CAS:<p>PKN1/2-IN-1 is a potent and selective PKN2 inhibitor, membrane permeability and anticancer.Protein kinase N proteins (PKN) are effectors of Rho GTPases.</p>Formula:C14H15N3OPurity:99.72%Color and Shape:SolidMolecular weight:241.29BiBET
CAS:<p>BiBET is a potent, selective, bivalent inhibitor of BET bromodomains.</p>Formula:C26H30N10O3Color and Shape:SolidMolecular weight:530.58KDM2B-IN-3
CAS:<p>KDM2B-IN-3, from patent WO2016112284A1 as compound 183c, potently inhibits histone demethylase KDM2B, with cancer research potential.</p>Formula:C25H30N2O2Color and Shape:SolidMolecular weight:390.52GS-626510
CAS:<p>GS-626510 is an orally bioavailable inhibitor of BET family bromodomains (Kd: 0.59-3.2 nM for BRD2/3/4; IC50: 83 nM and 78 nM for BD1 and BD2).</p>Formula:C25H22N4OColor and Shape:SolidMolecular weight:394.47AMPK activator
CAS:<p>AMPK activator</p>Formula:C22H21FO4Purity:98%Color and Shape:SolidMolecular weight:368.41,2-Didecanoylglycerol
CAS:<p>1,2-Didecanoylglycerol has functions as bioregulator of protein kinase C in human platelets.</p>Formula:C23H44O5Color and Shape:SolidMolecular weight:400.59LW479
CAS:<p>LW479 is a novel inhibitor of HDAC and is a promising candidate for the prevention of breast cancer.</p>Formula:C21H23BrN2O4SColor and Shape:SolidMolecular weight:479.39NSD3-IN-1
CAS:<p>NSD3-IN-1, a histone methyltransferase NSD3 inhibitor, demonstrates an IC50 of 28.58 μM.</p>Formula:C13H13N5OSColor and Shape:SolidMolecular weight:287.34HPB
CAS:<p>HPB is a selective HDAC6 deacetylase inhibitor</p>Formula:C18H20N2O4Color and Shape:SolidMolecular weight:328.36KDM5A-IN-1
CAS:<p>KDM5A-IN-1 is a pan-histidine lysine demethylase 5 KDM5 inhibitor that inhibits KDM5A, KDM5B, and KDM5C.Can be used in the study of cancer.</p>Formula:C15H22N4O2Purity:>99.99%Color and Shape:SolidMolecular weight:290.36Galegine hydrochloride
CAS:<p>Galegine hydrochloride, from G. officinalis, leads to weight loss, activates AMPK in various cells, and has antibacterial properties.</p>Formula:C6H14ClN3Color and Shape:SolidMolecular weight:163.65DC_517
CAS:<p>DC_517 is an inhibitor of DNA methyltransferase 1 (DNMT1) ( IC50: 1.7 μM; Kd: 0.91 μM).</p>Formula:C33H35N3O2Color and Shape:SolidMolecular weight:505.65HDAC-IN-43
CAS:<p>HDAC-IN-43: potent HDAC 1/3/6 inhibitor (IC50: 82 nM HDAC1, 45 nM HDAC3, 24 nM HDAC6); weak PI3K/mTOR (IC50: 3.6μM, 3.7μM); anti-proliferative.</p>Formula:C22H28N6O4Color and Shape:SolidMolecular weight:440.5L 888607 Racemate
CAS:<p>L 888607 Racemate blocks DP1 and TP receptors with 132 nM and 17 nM affinity.</p>Formula:C19H15ClFNO2SColor and Shape:SolidMolecular weight:375.84Tyk2-IN-7
CAS:<p>Tyk2-IN-7 is an inhibitor of TYK2 JH2, binds to the TYK2 JH2 domain (IC50: 0.00053 μM; Ki.app: 0.00007 μM).</p>Formula:C18H15D3N6O3SPurity:98%Color and Shape:SolidMolecular weight:401.46TK4b
CAS:<p>TK4b, a JAK inhibitor, targets leukemia/lymphoid diseases, with IC50s: 18.42 nM (JAK3) & 19.40 nM (JAK2).</p>Formula:C21H22N2O2Color and Shape:SolidMolecular weight:334.41Pulrodemstat Methylbenzenesulfonate
CAS:<p>LSD1-IN-7 Methylbenzenesulfonate is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity.</p>Formula:C31H31F2N5O5SPurity:98%Color and Shape:SolidMolecular weight:623.67ZIKV-IN-3
CAS:<p>ZIKV-IN-3, an andrographolide derivative, inhibits ZIKV NS5 MTase (IC50: 18.34 μM) and replication. Used for Zika virus research.</p>Formula:C39H41NO4Color and Shape:SolidMolecular weight:587.75YM-53601 free base
CAS:<p>YM-53601 free base is an inhibitor of squalene synthetase which suppresses lipogenic biosynthesis and lipid secretion in rodents.</p>Formula:C21H21FN2OPurity:98%Color and Shape:SolidMolecular weight:336.4EP009
CAS:<p>EP009, a novel, selective, and orally active inhibitor of JAK3, induces therapeutic response in T-cell malignancies.</p>Formula:C14H24O2Color and Shape:SolidMolecular weight:224.34MDK8228
CAS:<p>MDK8228 is an inhibitor of CBP/p300 and BRD4 bromodomain. MDK8228 downregulates IL-6, IL-ß and IFN-ß in macrophages.</p>Formula:C31H41N5O3Color and Shape:SolidMolecular weight:531.69NVS-BET-1
CAS:<p>NVS-BET-1 is a BET bromodomain inhibitor. NVS-BET-1 can regulate keratinocyte plasticity.</p>Formula:C22H21ClN4O2Color and Shape:SolidMolecular weight:408.88SIRT2-IN-11
CAS:<p>SIRT2-IN-11 (AEM1), a SIRT2 inhibitor (IC50 18.5μM), induces apoptosis and affects p53, used in cancer research.</p>Formula:C21H22N2OColor and Shape:SolidMolecular weight:318.41RM65
CAS:<p>RM65 is an arginine methyltransferase inhibitor.</p>Formula:C34H32N2O4S2Purity:98%Color and Shape:SolidMolecular weight:596.76HIF-1α-IN-3
CAS:<p>HIF-1α-IN-3, also known as Compound (S)-3f, is a hypoxia-selective inhibitor of HIF-1α. It exhibits potent antiestrogenic activity [1].</p>Formula:C19H17N5O2Color and Shape:SolidMolecular weight:347.37CBB1003
CAS:<p>CBB1003 is a new inhibitor of histone demethylase LSD1 (IC50: 10.54 μM).</p>Formula:C25H31N9O4Purity:98%Color and Shape:SolidMolecular weight:521.57PF-739
CAS:<p>PF-739 is an AMPK agonist that has been shown to activate AMPK in hepatocytes and skeletal muscle.</p>Formula:C23H23ClN2O5Purity:98%Color and Shape:SolidMolecular weight:442.89HDAC-IN-29
CAS:<p>HDAC-IN-29 (compound 13b) is a potent pan- HDAC inhibitor with antitumor activity.</p>Formula:C20H23N3O4SColor and Shape:SolidMolecular weight:401.48DC-BPi-03
CAS:<p>DC-BPi-03 is a potent BPTF-BRD inhibitor with an IC 50 of 698.3 nM and a K d of 2.81 μM .</p>Formula:C14H14N4O2SPurity:98.96%Color and Shape:SolidMolecular weight:302.35Butyrolactone 3
CAS:<p>Butyrolactone 3 (MB-3) is a Gcn5 inhibitor with weak affinity for CBP.Butyrolactone 3 has antimicrobial activity and can be used in cancer.</p>Formula:C9H12O4Purity:98.99% - 99.5%Color and Shape:SolidMolecular weight:184.19EZH2-IN-13
CAS:<p>EZH2-IN-13 is a potent EZH2 inhibitor with potential anticancer activity.EZH2-IN-13 may be used to study diseases associated with EZH2 activity.</p>Formula:C34H45N5O3Purity:98.3%Color and Shape:SolidMolecular weight:571.75Butyzamide
CAS:<p>Butyzamide: oral Mpl activator, non-peptide, antagonizes TPO receptors, boosts hMpl, Ba/F3 cells, and enhances platelets in mice.</p>Formula:C29H32Cl2N2O5SPurity:99.51% - 99.83%Color and Shape:SoildMolecular weight:591.55TNG908
CAS:<p>TNG908, a brain-penetrant PRMT5 inhibitor, is 15x more selective for MTAP mutant vs WT lines, useful in cancer studies.</p>Formula:C21H23N5O2SPurity:98.08% - 98.24%Color and Shape:SolidMolecular weight:409.51PU139
CAS:<p>PU139 is a novel inhibitor of histone acetyltransferase (HAT).</p>Formula:C12H7FN2OSPurity:99.96%Color and Shape:SolidMolecular weight:246.26Crebinostat
CAS:<p>Crebinostat: potent HDAC inhibitor, boosts synapsin-1 in neurons, enhances memory and gene Egr1 expression in mice.</p>Formula:C20H23N3O3Purity:94.96%Color and Shape:SolidMolecular weight:353.41DCPLA-ME
CAS:<p>DCPLA-ME (2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester) is the methyl ester form of DCPLA and can be used to treat neurodegenerative</p>Formula:C21H38O2Purity:99.80%Color and Shape:SolidMolecular weight:322.53STS-E412
CAS:<p>STS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.</p>Formula:C15H15ClN4O2Purity:99.01%Color and Shape:SolidMolecular weight:318.76Raxofelast
CAS:<p>Raxofelast (IRFI-016), a vitamin-like, hydrophilic antioxidant, mitigates ischemia-reperfusion in testis and may treat diabetic issues and atherosclerosis.</p>Formula:C15H18O5Purity:99.74% - 99.97%Color and Shape:SolidMolecular weight:278.3BAY-299
CAS:<p>BAY-299 inhibits BRPF2, TAF1, and TAF1L with IC50s of 67, 8, and 106 nM.</p>Formula:C25H23N3O4Purity:99.53%Color and Shape:SolidMolecular weight:429.47LEM-14
CAS:<p>LEM-14 is a potent NSD2-specific inhibitor (IC50:132 μM).LEM-14 may be used in the study of multiple myeloma.</p>Formula:C25H26N4O4SPurity:98.3%Color and Shape:SolidMolecular weight:478.56CMP-5
CAS:<p>CMP-5 is a PRMT5 inhibitor with antiviral activity, inhibits PRMT5 methyltransferase activity, and can be used in the study of SARS virus infection.</p>Formula:C21H21N3Purity:98.68%Color and Shape:SolidMolecular weight:315.41TM2-115
CAS:<p>TM2-115 is a inhibitor of malaria parasite histone methyltransferases that results in rapid and irreversible parasite death [1].</p>Formula:C28H38N6O2Purity:97.67%Color and Shape:SolidMolecular weight:490.64ZEN-3219
CAS:<p>ZEN-3219 is a BET inhibitor, which has inhibitory effect on BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2).</p>Formula:C19H18N2O3Purity:99.06%Color and Shape:SolidMolecular weight:322.36TGP-377/421
CAS:<p>TGP-377/421 (Targapre-miR-377/421) is a potent miR-377 and miR-421 dual inhibitor that inhibits miR-377 and miR-421 by binding to their functional sites.</p>Formula:C20H16N6Purity:98.48%Color and Shape:SolidMolecular weight:340.38DW14800
CAS:<p>DW14800 is an inhibitor of PRMT5 (IC50 = 17 nM), enhances the transcription of HNF4α, and reduces the level of H4R3me2s.</p>Formula:C31H36N4O3Purity:99.55% - 99.68%Color and Shape:SolidMolecular weight:512.64Cedazuridine
CAS:<p>Cedazuridine ((4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine) is an oral inhibitor of cytidine deaminase with antineoplastic properties.</p>Formula:C9H14F2N2O5Purity:99.66%Color and Shape:SolidMolecular weight:268.21CEP-9722
CAS:<p>CEP-9722 is a PARP-1 and PARP-2 inhibitor with anticancer activity and is used in the study of ovarian cancer.</p>Formula:C24H26N4O3Purity:98.38% - 98.56%Color and Shape:SolidMolecular weight:418.49GRK6-IN-1
CAS:<p>GRK6-IN-1 (compound 18) is a potent GRK6 blocker, with an IC50 of 120 nM, showing promise for multiple myeloma research.</p>Formula:C22H23ClN6O2Purity:99.37%Color and Shape:SolidMolecular weight:438.91Procainamide
CAS:<p>Procainamide: DNMT1 inhibitor, Class 1A antiarrhythmic, promising for cancer and arrhythmia research.</p>Formula:C13H21N3OPurity:99.92% - 99.92%Color and Shape:SolidMolecular weight:235.33CPUY074020
CAS:<p>CPUY074020 is a potent and orally bioavailable inhibitor of histone methyltransferase G9a (IC50: 2.18 μM) with anti-proliferative activity.</p>Formula:C25H28N4O2Purity:98.64%Color and Shape:SolidMolecular weight:416.52
